logical dysfunctions of HERG or KCNQ K + channels are one of the primary triggers of cardiac diseases such as arrhythmias. Since arrhythmias are a major cause of sudden cardiac death in the world [2] , HERG as well as KCNQ K + channels are the principal pharmacological targets for development of therapeutic drugs against cardiovascular diseases including arrhythmias.
Ginseng, the root of Panax ginseng Meyer, has been used as a general tonic to promote longevity and enhance bodily functions against stress, fatigue, diseases, cancer and diabetes mellitus [4] . Among various ginseng components, ginsenosides (also called ginseng saponins) exhibit anti-hypertension and cardio-protective effects [5] . In a previous study, we demonstrated that ginsenoside Rg 3 (Rg 3 ) enhanced cardiac I Ks channel currents, which consist of KCNQ1 plus KCNE1 subunits in both concentration-and voltage-dependent manners [6] . In addition, we also demonstrated that Rg 3 enhanced outward currents (I HERG ) and transient tail currents (I tail ). Rg 3 induced a large persistent deactivating-tail current (I deactivataing-tail ) and significantly decelerated deactivating current decay [7] .
On the other hand, ginsenosides administered via the oral route can pass into the large intestine without being broken down by either gastric juices or digestive enzymes [8] . But protopanaxadiol (PPD) ginsenosides are metabolized by intestinal microorganisms into compound K (CK) with one glucose at the C-20 position and are further metabolized to form PPD without glucose, whereas protopanaxatriol (PPT) ginsenosides are metabolized to PPT that only maintains the backbone structure of ginsenosides without any carbohydrate component (Fig. 1) . The purpose of this study was to investigate how ginsenoside metabolites affect HERG K + channel activity. We report here that CK decelerated HERG K + channel deactivation, whereas PPT accelerated HERG K + channel deactivation. PPD itself had no effect on HERG K + channel activity but antagonized Rg 3 -mediated HERG K + channel regulations. These results indicate that ginsenoside metabolites exhibit differential regulation on HERG K + channel activity.
MATERIALS AND METHODS

Materials
The individual ginsenoside Rg 3 and ginsenoside metabolites such as PPD, PPT, and CK were provided by AMBO Institute (Seoul, Korea) (Fig. 1A) . The cDNAs for human HERG K + channels (accession no. U04270) were kindly provided by Dr. Pongs (University of Hamburg, Germany). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Preparation of Xenopus oocytes and microinjection
Xenopus laevis frogs were purchased from Xenopus I (Ann Arbor, MI, USA). Their care and handling were in accordance with the highest standards of institutional guidelines of Konkuk University. For isolation of oocytes, frogs were anesthetized with an aerated solution of 3-amino benzoic acid ethyl ester followed by removal of ovarian follicles. The oocytes were treated with collagenase and then agitated for 2 h in Ca 2+ -free medium containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, 2.5 mM sodium pyruvate, 100 units/mL penicillin and 100 μg/mL streptomycin. Stage V-VI oocytes were collected and stored in ND96 medium (in mM: 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , and 5 HEPES, pH 7.5) supplemented with 50 µg/mL gentamicin. The oocytecontaining solution was maintained at 18°C with continuous gentle shaking and renewed daily. Electrophysiological experiments were performed within 5-6 days of oocyte isolation, with ginsenoside Rg 3 or ginsenoside metabolites added to the bath. For HERG K + channel experiments, HERG K + channel-encoding cRNAs (40 nL) were injected into the animal or vegetal pole of each oocyte one day after isolation, using a 10 µl microdispenser (VWR Scientific, San Francisco, CA, USA) fitted with a tapered glass pipette tip (15-20 µm in diameter) [9] . 
Data recording
A custom-made Plexiglas net chamber was used for two-electrode voltage-clamp recordings as previously reported [7] . The oocytes were impaled with two microelectrodes filled with 3M KCl (0.2-0.7 MW), and electrophysiological experiments were carried out at room temperature using an Oocyte Clamp (OC-725C; Warner Instruments, Hamsden, CT, USA). Stimulation and data acquisition were controlled with a pClamp 8 (Axon Instruments, Union City, CA, USA). For most electrophysiological experiments, oocytes were initially perfused with ND96 solution (in mM: 96 NaCl, 3 KCl, 2 CaCl 2 , 5 HEPES, pH 7.4 with NaOH) to obtain control current recordings. The oocytes were then clamped at a holding potential of -90 mV, the membrane potential was depolarized to 0 mV for 4 s, followed by repolarization to -60 mV at 20 s intervals, and current values were recorded.
Data analysis
To obtain the concentration-response curve of the respective ginsenoside metabolites effects on the K + current from the HERG K + channel, the peak amplitudes at various concentrations of the respective ginsenoside metabolites were plotted, and Origin software (Origin, Northampton, MA, USA) was used to fit the plot to the ), where y is the peak current at a given concentration of ginsenoside metabolite, y max is the maximal peak current, EC 50 is the concentration of the respective ginsenoside metabolite producing a half-maximal effect, [A] is the concentration of the respective ginsenoside metabolite, and nH is the Hill coefficient. All values were presented as the mean±SEM. The significance of differences between mean control and treatment values was determined using Student's t-test, where p<0.05 was considered statistically significant.
RESULTS AND DISCUSSION
Effects of CK on HERG K + channel currents We first examined the effect of intermediate ginsenoside metabolite CK on the HERG K + channel currents using a Xenopus oocyte gene expression system. HERG K + channel currents were recorded using the two-electrode voltage-clamp recording technique at room temperature [10] . Throughout these experiments, the holding potential was maintained at -90 mV and repolarized to -60 mV after depolarizing pulses from 0 mV, unless otherwise indicated. Fig. 2A gives an example of a voltageclamp recording with the representative current traces of I HERG at end of depolarization, transient peak I tail , and slow I deactivating-tail as indicated by arrows in the absence or presence of various concentrations of CK. CK had almost no effect on I HERG and I tail ( Fig. 2A) . Interestingly, CK showed a major effect on slow I deactivating-tail . Thus in the presence of CK, I deactivating-tail failed to decay, and instead, a large persistent outward current developed. CK (100 mM) increased slow I deactivating-tail by an average of 97.8±8.13% compared to control ( Fig. 2A) . CK response was completely reversible upon washing the oocytes with ND96 (data not shown). Next, we examined the concentration-dependent effect of CK on I HERG , I tail , and slow I deactivating-tail . As shown in Fig. 2B , CK had a negligible effect on both I HERG and I tail . CK also increased a persistent I deactivating-tail in a concentration-dependent manner. The EC 50 value was16.6±1.3 µM for slow I deactivating-tail .
Next, we investigated the HERG K + current-voltage (I-V) relationship using CK (Fig. 2C, D) . The amplitude of I HERG measured at the end of depolarization increased with increasing positive voltage steps, reaching a maximum at -10 mV and then progressively decreased with further voltage steps in the control, indicating that HERG K + channel is activated with rectified manner (Fig. 2C, D) . When the amplitude of I HERG was normalized to the maximum amplitude of the I HERG obtained under the control conditions and was plotted against the potential of the step depolarization (Fig. 2C, D) , the presence of various concentrations of CK did not show a significant increase of I HERG even at high concentrations of CK, indicating that CK mainly affects slow I deactivating-tail .
We next examined whether CK affects steady-state activation (Fig. 2E) . Treatment of 10 and 30 mM CK caused significant leftward shifts in steady-state activation curves compared to control oocytes. The V 1/2 values were -25.5±0.39 mV in the control and -24.6±0.43, -30.9±0.50 and -32.4±0.82 mV in the presence of 3, 10, and 30 mM CK-treated groups, respectively (p<0.05 at 10 and 30 mM Rg 3 compared to control, n=5). The slope factors (kg) were not significantly changed, yielding values of 6.7±0.34 in control and 6.3±0.37, 6.1±0.44 and 6.5±0.70 in the presence of 3, 10 and 30 mM CK-treated groups, respectively. We also examined CK (30 mM) and observed that it did not affect steady-state inactivation (data not shown). Therefore, these results indicate that CK affects the activation gating rather than inactivation gating of HERG K + channels.
Effects of PPT on HERG K + channel currents PPT had no effects on I HERG and I tail as observed with CK. However, PPT showed a significant effect on slow I deactivating-tail . As a result, in the presence of PPT, I deactivating-tail accelerated to decay in contrast to CK. PPT (100 mM) decreased slow I deactivating-tail by an average of 88.2±1.3% compared to control (Fig. 3A) . PPT response was also completely reversible upon washing the oocytes with ND96 (data not shown). Next, we examined the concentration-dependent effect of PPT on I HERG , I tail , and slow I deactivating-tail . As shown in Fig. 3B , PPT showed a slight inhibition on I tail but a negligible effect on I HERG , however PPT primarily inhibited I deactivating-tail in a concentration- Currents were recorded at test potential from -60 to +50 mV. I tail and I deactivating-tail were recorded after repolarization to -60 mV. (D) I-V relationships for HERG K + currents measurement at the end of the 4-s test pulse before and after application of 3, 10, and 30 µM CK (n=5). Currents were normalized to the control current at 0 mV for each oocyte. Data are represented by the means±SEM (n=7). (E) Effects of CK on the steady-state activation curve for HERG K + channel. I tail were normalized to the peak current under each condition, and the data were fitted with a Boltzmann function. Treatment of CK (10, 30, and 100 µM) did cause a leftward shift. Con, control. + Channel.
http://ginsengres.org dependent manner. Interestingly, PPT had a considerable effect on I deactivating-tail compared to I HERG and I tail . The IC 50 value was 27.5±2.3 µM for slow I tail , while the IC 50 value was 10.6±0.5 µM for slow I deactivating-tail .
Next, we examined the HERG K + current-voltage (I-V) relationship using PPT (Fig. 3C, D) . The amplitude of I HERG measured at the end of depolarization increased with increasing positive voltage steps, reaching a maximum at -10 mV and then progressively decreased with further voltage steps in the control, indicating that HERG K + channel rectifies (Fig. 3C, D) . When the amplitude of I HERG was normalized to the maximum amplitude of the I HERG obtained under the control conditions and was plotted against the potential of the step depolarization (Fig.   Fig. 3 . Effects + currents measurement at the end of the 4-s test pulse before and after application of 3, 10, and 30 µM PPT (n=5). Currents were normalized to the control current at 0 mV for each oocyte. Data are represented by the means±SEM (n=7). (E) Effects of PPT on the steady-state activation curve for HERG K + channel. I tail were normalized to the peak current under each condition, and the data were fitted with a Boltzmann function. Treatment of PPT (3, 10, and 30 µM) did not cause a leftward shift. Con, control.
3C, D), the presence of various concentrations of PPT did not show a significant increase of I HERG even at high concentrations of PPT, indicating that PPT mainly affects slow I deactivating-tail .
We next set forth to determine whether PPT affects steady-state activation (Fig. 3E) . Treatment of 10 and 30 mM PPT did induce slightly but not significant leftward shifts in steady-state activation curves compared to control oocytes. The V 1/2 values were -22.6±0.37 mV in the control and -28.7±1.35, -29.1±1.43 and -30.1±0.46 mV in the presence of 3, 10, and 30 mM PPT-treated groups, respectively (p<0.08 at 10 and 30 mM Rg 3 compared to control, n=5). The slope factors (kg) were not significantly changed, yielding values of 7.9±0.33 in control and 4.8±0.09, 5.2±1.29 and 6.3±0.39 in the presence of 3, 10 and 30 mM PPT-treated groups, respectively. We also examined PPT (100 mM) and observed that it did not affect steady-state inactivation (data not shown). Therefore, these results indicate that PPT affects the activation gating rather than inactivation gating of HERG K + channels.
Effects of PPD on HERG K + channel currents PPD itself had nearly no effects on IHERG, I tail , and slow I deactivating-tail (Fig. 4A) . However, PPD showed an inhibition on Rg 3 -mediated enhancement on slow I deactivatingtail . Hence in the presence of PPD, Rg 3 -induced persistent I deactivating-tail was greatly attenuated. PPD effect on Rg 3 -induced persistent I deactivating-tail was completely reversible upon washing the oocytes with ND96 (data not shown). We subsequently examined the concentration-dependent effect of PPD on Rg 3 -induced persistent I deactivating-tail . As shown in Fig. 4B , PPD showed a negligible effect on I HERG and I tail but PPD greatly attenuated Rg 3 -induced persistent I deactivating-tail in a concentration-dependent manner. Interestingly, PPD caused a rightward shift of Rg 3 -induced persistent I deactivating-tail from 0.5±0.04 to 2.9±0.57 µM for slow I deactivating-tail (Fig. 4C) .
We then studied the HERG K + current-voltage (I-V) relationship using PPD on Rg 3 -induced enhancement of I HERG (Fig. 4B) . The amplitude of I HERG measured at the end of depolarization increased with increasing positive voltage steps, reaching a maximum at -10 mV and then progressively decreased with further voltage steps in the control, indicating that HERG K + channel rectifies (Fig.  4B) . When the amplitude of I HERG was normalized to the maximum amplitude of the I HERG obtained under the control conditions and was plotted against the potential of the step depolarization (Fig. 4B) , the presence of various concentrations of PPD did not show a significant increase of I HERG even at high concentrations of PPD, indicating that PPD mainly affects Rg 3 -induced persistent I deactivating-tail .
Our following goal was to examine whether PPD affects steady-state activation (Fig. 3E) . In contrast to CK or PPT, co-treatment of 10 and 30 mM PPD with Rg 3 did not affect on Rg 3 -caused leftward shifts in steadystate activation curves compared to control oocytes. The V 1/2 values were -21.7±0.18 mV in the control and -21.2±0.35, -24.6±0.27 and -24.6±0.28 mV in the presence of 3, 10, and 30 mM PPD-treated groups, respectively (p<0.07 at 10 and 30 mM Rg 3 compared to control, n=5). The slope factors (kg) were not significantly changed, yielding values of 7.9±0.16 in control and 8.7±0.31, 7.5±0.24 and 7.5±0.25 in the presence of 3, 10 and 30 mM PPD-treated groups, respectively. We also examined PPD (100 mM) and observed that it did not affect steady-state inactivation (data not shown). These results suggest PPD affects the activation gating rather than inactivation gating of HERG K + channels. Ginsenosides consist of aglycone and carbohydrates portions. The aglycone is the backbone of the ginsenoside, with a hydrophobic four-ring steroid-like structure that may be non-polar, whereas the carbohydrates on carbons-3, 6, and 20 of the backbone are polar (Fig. 1A) . In vitro and in vivo studies have shown that ginsenosides administered by an oral route were metabolized and finally become an agylcone such as CK which has one glucose at the C-20, PPD and PPT [8] . Recent report showed that these ginsenoside metabolites might also induce apoptosis of the cancer cells and play a role as an anti-cancer agent [8, 11] , suggesting that ginsenosides are pro-drugs of these metabolites. However, relatively little is known regarding how ginsenoside metabolites regulate ion channel or receptor activity.
In the present study, we report three major findings. First, we observed that CK decelerated deactivating time constants in both concentration-and voltage-dependent manners, whereas CK had no effects on I HERG and I tail , Second, we found that PPT accelerated I deactivating-tail deactivation in both concentration-and voltage-dependent manners without affecting on I HERG and I tail . Third, PPD itself had no effect on I HERG , I tail , and I deactivating-tail . However, co-treatment of PPD with Rg 3 blocked Rg 3 -mediated decelerating effects on I deactivating-tail . Thus, the major findings of the present study are that ginsenoside metabolites had no significant effects on I HERG and I tail of HERG K + channel but they did affect I deactivating-tail in differing manners, indicating that ginsenoside metabolites show a differential regulation of I deactivating-tail with respect to the HERG K + channel. On the other hand, we demonstrated in previous stud-+ Channel.
http://ginsengres.org ies that ginsenoside metabolites such as CK, PPD and PPT regulate ion channels and receptors. For example, CK but not PPT caused strong inhibition of the voltagedependent α1G-type Ca 2+ channel [12] . Similarly, we have also found that CK but not M4 (PPT) inhibited a neuronal Na + (Nav1.2) channel [13] . We demonstrated that M4, but not CK, exhibited an inhibitory effect on 5-HT 3A receptor-mediated currents [14] . In addition, CK and PPT exhibited an inhibitory effect on a3b4 nicotinic acetylcholine receptor-mediated currents [15] . All these findings indicate that ginsenoside metabolites as well as ginsenosides have regulatory effects on voltage-dependent ion channel and receptor activities.
Since the HERG K + channel regulators are clinically important for treatment of cardiac diseases such as arrhythmia, there are numerous reports on the development Vol. 35, No. 2, 191-199 (2011) of HERG K + channel regulators from natural compounds [16] . In the previous study, we found that Rg 3 increased I HERG and peak I tail . In addition, Rg 3 profoundly delayed deactivation kinetics by inducing a persistent I deactivating-tail and caused a leftward shift of steady-state voltage-dependent activation but not inactivation, leading to the possibility that Rg 3 is an activator to open HERG K + channel at a more negative voltage step than control and that Rg 3 mainly works by slowing closure of the HERG K + channel once it has opened. In the present study, when we examined the effects of ginsenoside metabolites on HERG K + channel currents, we found that CK induced a persistent I deactivating-tail and caused a leftward shift of steady-state voltage-dependent activation (Fig. 2) . However, the effective concentration of CK was higher than that of Rg 3 . In contrast to CK, PPT caused an acceleration of I deactivatingtail decay (Fig. 3) . Interestingly, co-treatment of PPD with Rg 3 blocked Rg 3 -mediated deceleration of deactivation process. It is noteworthy that since Rg 3 became PPD after metabolic process, PPD-mediated antagonism of Rg 3 action on HERG K + channel activity show the possibility that aglycone, PPD, ginsenoside Rg 3 and other PPD ginsenosides might interfere with in vivo Rg 3 actions on HERG K + channel activity. Taken together, we found that CK decelerated the deactivation process by inducing a persistent I deactivating-tail with delayed deactivation in HERG K + channel without affecting I HERG and I tail . In contrast, PPT accelerated the deactivation process by inducing an inhibition of I deactivating-tail without affecting I HERG and I tail . PPD itself had no observable effects on I HERG , I tail , and I deactivating-tail but cotreatment of PPD with Rg 3 blocked Rg 3 -mediated a persistent I deactivating-tail with delayed deactivation in HERG K + channel. These novel findings provide an insight into the molecular action of ginsenoside metabolites on HERG K + channel activity.
